T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Columbia Financial
CLBK
$1.22B
| $21.3M | ﹤0.01% |
1,527,379
+457
| +0% | +$6.38K |
|
|
BNR
1127
Burning Rock Biotech
BNR
$98M
| $21.3M | ﹤0.01% |
+78,890
| New | +$21.6M |
|
1128
Natera
NTRA
$44.8B
| $21.1M | ﹤0.01% |
423,209
-91,690
| -18% | -$3.68M |
|
1129
Carter's
CRI
$1.44B
| $20.8M | ﹤0.01% |
258,244
-303,026
| -54% | -$24.1M |
|
1130
Seagate
STX
$209B
| $20.8M | ﹤0.01% |
430,451
-37,369
| -8% | -$1.88M |
|
1131
Boston Omaha
BOC
$431M
| $20.8M | ﹤0.01% |
+1,298,717
| New | +$21.7M |
|
|
PCSB
1132
DELISTED
PCSB Financial Corporation
PCSB
| $20.8M | ﹤0.01% |
1,638,678
+22,027
| +1% | +$287K |
|
1133
Regions Financial
RF
$27B
| $20.8M | ﹤0.01% |
1,867,735
-126,451
| -6% | -$1.35M |
|
|
CYBR
1134
DELISTED
CyberArk
CYBR
| $20.8M | ﹤0.01% |
209,089
-10,076
| -5% | -$981K |
|
|
VAR
1135
DELISTED
Varian Medical Systems, Inc.
VAR
| $20.6M | ﹤0.01% |
168,475
-12,724
| -7% | -$1.47M |
|
1136
Stepan Co
SCL
$1.48B
| $20.6M | ﹤0.01% |
211,673
-5,122
| -2% | -$482K |
|
1137
Citizens Financial Group
CFG
$31.2B
| $20.5M | ﹤0.01% |
814,095
-56,546
| -6% | -$1.28M |
|
1138
Live Nation Entertainment
LYV
$43.3B
| $20.5M | ﹤0.01% |
463,528
-320,187
| -41% | -$14M |
|
1139
NCR Voyix
VYX
$1.17B
| $20.4M | ﹤0.01% |
1,920,755
-87,907
| -4% | -$1.01M |
|
|
CTRA
1140
DELISTED
Coterra Energy
CTRA
| $20.3M | ﹤0.01% |
1,183,727
-224,285
| -16% | -$4.35M |
|
1141
International Seaways
INSW
$4.71B
| $20.3M | ﹤0.01% |
1,241,786
-147,372
| -11% | -$3.2M |
|
1142
Hubbell
HUBB
$26.8B
| $20.3M | ﹤0.01% |
161,656
-2,907
| -2% | -$354K |
|
1143
Workiva
WK
$4.01B
| $20.2M | ﹤0.01% |
378,234
-1,320,472
| -78% | -$54.1M |
|
1144
PENN Entertainment
PENN
$2.53B
| $20.2M | ﹤0.01% |
661,657
-1,238,381
| -65% | -$28.4M |
|
1145
UDR
UDR
$12.2B
| $20.2M | ﹤0.01% |
540,027
-43,475
| -7% | -$1.62M |
|
|
ICPT
1146
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $20.1M | ﹤0.01% |
420,459
-128,423
| -23% | -$9.92M |
|
|
ECOL
1147
DELISTED
US Ecology, Inc.
ECOL
| $20M | ﹤0.01% |
590,370
-90,125
| -13% | -$2.94M |
|
|
HBMD
1148
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $19.9M | ﹤0.01% |
1,870,033
+128,213
| +7% | +$1.31M |
|
1149
BioNTech
BNTX
$23.1B
| $19.8M | ﹤0.01% |
+297,000
| New | +$14.8M |
|
1150
Universal Health Services
UHS
$10.1B
| $19.7M | ﹤0.01% |
212,120
-49,536
| -19% | -$4.95M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.